• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如果大麻会导致精神分裂症——为了预防一例精神分裂症,需要预防多少大麻使用者?英格兰和威尔士的计算。

If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations.

机构信息

Social Medicine, University of Bristol, Canynge Hall, Bristol BS8 2PR, UK.

出版信息

Addiction. 2009 Nov;104(11):1856-61. doi: 10.1111/j.1360-0443.2009.02736.x.

DOI:10.1111/j.1360-0443.2009.02736.x
PMID:19832786
Abstract

BACKGROUND

We consider how many cannabis users may need to be prevented in order to prevent one case of schizophrenia or psychosis [defined as number needed to prevent (NNP)].

METHOD

Calculation for England and Wales using best available estimates of: incidence of schizophrenia; rates of heavy and light cannabis use; and risk that cannabis causes schizophrenia.

RESULTS

In men the annual mean NNP for heavy cannabis and schizophrenia ranged from 2800 [90% confidence interval (CI) 2018-4530] in those aged 20-24 years to 4700 (90% CI 3114-8416) in those aged 35-39. In women, mean NNP for heavy cannabis use and schizophrenia ranged from 5470 (90% CI 3640-9839) in those aged 25-29 to 10 870 (90% CI 6786-22 732) in 35-39-year-olds. Equivalent mean NNP for heavy cannabis use and psychosis were lower, from 1360 (90% CI 1007-2124) in men aged 20-24 and 2480 (90% CI 1408-3518) in women aged 16-19. The mean and median number of light cannabis users that would need to be prevented in order to prevent one case of schizophrenia or psychosis per year are four to five times greater than among heavy users.

CONCLUSIONS

The number of young people who need to be exposed to an intervention to generate NNP and prevent one case of schizophrenia will be even larger. The public health importance of preventing cannabis to reduce schizophrenia or psychosis remains uncertain. More attention should be given to testing the hypothesis that cannabis is related causally to psychotic outcomes, and to considering what strategies will be the most effective in reducing heavy cannabis use among young people.

摘要

背景

我们考虑需要预防多少大麻使用者,以防止出现一例精神分裂症或精神病[定义为需要预防的人数(NNP)]。

方法

使用最佳可用估计值,针对英格兰和威尔士进行计算:精神分裂症的发病率;重度和轻度大麻使用的比率;以及大麻导致精神分裂症的风险。

结果

在男性中,20-24 岁年龄组重度大麻和精神分裂症的年平均 NNP 范围为 2800(90%置信区间(CI)2018-4530),35-39 岁年龄组为 4700(90% CI 3114-8416)。在女性中,25-29 岁年龄组重度大麻使用和精神分裂症的平均 NNP 范围为 5470(90% CI 3640-9839),35-39 岁年龄组为 10870(90% CI 6786-22732)。重度大麻使用和精神病的等效平均 NNP 较低,20-24 岁男性为 1360(90% CI 1007-2124),16-19 岁女性为 2480(90% CI 1408-3518)。为了预防每年一例精神分裂症或精神病,需要预防四到五个轻度大麻使用者。

结论

需要接触干预措施以产生 NNP 并预防一例精神分裂症的年轻人数量将会更大。预防大麻以减少精神分裂症或精神病的公共卫生重要性仍不确定。应该更加关注测试大麻与精神病结果之间存在因果关系的假设,并考虑哪些策略在减少年轻人重度大麻使用方面最有效。

相似文献

1
If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations.如果大麻会导致精神分裂症——为了预防一例精神分裂症,需要预防多少大麻使用者?英格兰和威尔士的计算。
Addiction. 2009 Nov;104(11):1856-61. doi: 10.1111/j.1360-0443.2009.02736.x.
2
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.大麻与精神分裂症:关于英格兰和威尔士大麻使用增加对精神分裂症历史及未来趋势影响的模型预测
Addiction. 2007 Apr;102(4):597-606. doi: 10.1111/j.1360-0443.2006.01710.x.
3
Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.大麻、精神分裂症和其他非情感性精神病:基于人群的队列研究 35 年随访结果。
Psychol Med. 2012 Jun;42(6):1321-8. doi: 10.1017/S0033291711002078. Epub 2011 Oct 17.
4
A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.有或无既往大麻使用史的精神分裂症患者的症状及家族史比较:对大麻性精神病概念的启示
Schizophr Res. 2007 Jul;93(1-3):203-10. doi: 10.1016/j.schres.2007.03.014. Epub 2007 Apr 25.
5
Testing hypotheses about the relationship between cannabis use and psychosis.检验关于大麻使用与精神病之间关系的假设。
Drug Alcohol Depend. 2003 Jul 20;71(1):37-48. doi: 10.1016/s0376-8716(03)00064-4.
6
Cannabis use and psychotic disorders: an update.大麻使用与精神障碍:最新进展
Drug Alcohol Rev. 2004 Dec;23(4):433-43. doi: 10.1080/09595230412331324554.
7
Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.评估1996年至2005年期间大麻使用对英国确诊精神分裂症趋势的影响。
Schizophr Res. 2009 Sep;113(2-3):123-8. doi: 10.1016/j.schres.2009.05.031. Epub 2009 Jun 27.
8
Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.1994 年至 2016 年丹麦因大麻导致的精神病、其他物质导致的精神病以及同时诊断为精神分裂症和大麻使用障碍的年发病率。
Psychol Med. 2021 Mar;51(4):617-622. doi: 10.1017/S0033291719003532. Epub 2019 Dec 16.
9
[Cannabis and psychosis--a review].[大麻与精神病——综述]
Praxis (Bern 1994). 2004 Jun 2;93(23):997-1002. doi: 10.1024/0369-8394.93.23.997.
10
Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.大麻与神经精神病学,2:作为不良后果的精神病纵向风险
J Clin Psychiatry. 2016 Jun;77(6):e739-42. doi: 10.4088/JCP.16f10918.

引用本文的文献

1
Cannabis and Psychosis: Weeding Out Fact from Fiction.大麻与精神病:分清虚实
Mo Med. 2024 Sep-Oct;121(5):333-339.
2
Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis-related health problems among community cannabis users using social networking services.日本大麻使用障碍和大麻精神病的风险因素:利用社交网络服务对社区大麻使用者大麻相关健康问题进行调查的第二份报告。
Neuropsychopharmacol Rep. 2023 Mar;43(1):85-94. doi: 10.1002/npr2.12307. Epub 2022 Dec 19.
3
Early Intervention Services for Schizophrenia: Looking Back and Looking Ahead.
精神分裂症的早期干预服务:回顾与展望。
Schizophr Bull. 2022 May 7;48(3):544-550. doi: 10.1093/schbul/sbac024.
4
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues.当前治疗性大麻的争议与临床试验设计问题
Front Pharmacol. 2016 Sep 14;7:309. doi: 10.3389/fphar.2016.00309. eCollection 2016.
5
Genetic and Environmental Factors Associated with Cannabis Involvement.与大麻使用相关的遗传和环境因素。
Curr Addict Rep. 2016 Jun;3(2):199-213. doi: 10.1007/s40429-016-0103-1. Epub 2016 Apr 12.
6
Legalizing marijuana.使大麻合法化。
J Psychiatry Neurosci. 2016 Mar;41(2):75-6. doi: 10.1503/jpn.160012.
7
The early identification of psychosis: can lessons be learnt from cardiac stress testing?精神病的早期识别:能否从心脏压力测试中吸取经验教训?
Psychopharmacology (Berl). 2016 Jan;233(1):19-37. doi: 10.1007/s00213-015-4143-3. Epub 2015 Nov 14.
8
Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children.18岁时大麻和香烟使用与精神病体验的关联:雅芳亲子纵向研究的结果
Psychol Med. 2014 Dec;44(16):3435-44. doi: 10.1017/S0033291714000531. Epub 2014 Apr 10.
9
Genetic predisposition to schizophrenia associated with increased use of cannabis.与大麻使用增加相关的精神分裂症遗传易感性。
Mol Psychiatry. 2014 Nov;19(11):1201-4. doi: 10.1038/mp.2014.51. Epub 2014 Jun 24.
10
Cost benefit analysis of two policy options for cannabis: status quo and legalisation.两种大麻政策选择的成本效益分析:现状与合法化。
PLoS One. 2014 Apr 22;9(4):e95569. doi: 10.1371/journal.pone.0095569. eCollection 2014.